S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 41 to 80 of 109

Issue Date	Title / Author(s) / Citation	File
2010-06	Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy Yhim, Ho-Young; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Im, Seock-Ah; Kim, Tae-You; Kim, Young Tae; Noh, Dong-Young; Chie, Eui Kyu; Ha, Sung Whan; Park, In Ae; Bang, Yung-Jue Cancer, Vol.116 No.12, pp.2890-2901	DOI
2010-07	PIK3CA Mutations in In situ and Invasive Breast Carcinomas Miron, Alexander; Varadi, Maria; Carrasco, Daniel; Li, Hailun; Kim, Hee Jung; Cho, Eun Yoon; Kehoe, Sarah; Dillon, Deborah; Macconaill, Laura; Polyak, Kornelia; Gelman, Rebecca; Allred, D. Craig; Iglehart, J. Dirk; Lewis, Gretchen; Park, So Yeon; Luongo, Lauren CANCER RESEARCH; Vol.70 14; 5674-5678	DOI
2011-01	Age < 40 Years is an Independent Prognostic Factor Predicting Inferior Overall Survival in Patients Treated with Breast Conservative Therapy Kim, Kyubo; Chie, Eui Kyu; Han, Wonshik; Noh, Dong-Young; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. Breast Journal, Vol.17 No.1, pp.75-78	DOI
2011-02	Evaluation of CD24 expression as prognostic marker and therapeutic target in breast cancer 서지현	link
2011-02	Expression of Vitamin D-3-Upregulated Protein 1 in Human and Canine Mammary Glad Tumors 박준원	link
2011-02	Molecular marker analysis of effectiveness in patients with stage II/III breast cancer treated with paclitaxel/gemcitabine-based neoadjuvant chemotherapy 이근석	link
2011-02	Decreased phosphorylation of p90 RSK may predict poor response for neoajuvant chemotherapy in breast cancer 신희철	link
2011-02	Studies on functions of LSD1 for RORα2-dependent transcriptional activation in breast cancer 김경규	link
2011-05	Discordant human epidermal growth factor receptor 2 and hormone receptor status in primary and metastatic breast cancer and response to trastuzumab Chang, Hye Jung; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Jeon, Yoon Kyung; Park, In Ae; Han, Wonshick; Noh, Dong-Young; Bang, Yung-Jue; Kim, Tae-You Japanese Journal of Clinical Oncology, Vol.41 No.5, pp.593-599	DOI
2011-08	본인부담경감이 암환자의 의료이용에 미치는 영향 조성춘	link
2011-08	Prediction of response to docetaxel using mRNA expression and CpG methylation profiles in triple-negative breast cancer cell lines 김은규	link
2011-08	Environmental and genetic factors in breast cancer survival 이지영	link
2011-08	Genome-wide DNA methylation profiling in peripheral blood and breast cancer risk in Korean women Li, Lian	link
2011-10	Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy Keam, Bhumsuk; Im, Seock-Ah; Koh, Youngil; Han, Sae-Won; Oh, Do-Youn; Cho, Nariya; Kim, Jee Hyun; Han, Wonshik; Kang, Keon Wook; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Chung, June-Key; Bang, Yung-Jue BMC Cancer, Vol.11, p. 452	DOI
2012	Id2의 결핍이 종양의 발생에 미치는 영향에 대한 연구 최석원	link
2012-03	Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells Kim, Hye Jin; Kim, Hwang-Phill; Yoon, Young-Kwang; Kim, Maeng-Sup; Lee, Gwan-Sun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Anti-Cancer Drugs, Vol.23 No.3, pp.288-297	DOI
2012-08	Efficacy of a Web-based Self-management Exercise and Diet Intervention Program with Tailored Motivation and Action Planning for Breast Cancer Survivors: A Randomized Controlled Trial Lee, Myung Kyung	view file
2013-01	Breast Cancer Molecular Phenotype and the Use of HER2-Targeted Agents Influence the Accuracy of Breast MRI After Neoadjuvant Chemotherapy Moon, Hyeong-Gon; Han, Wonshik; Ahn, Soo Kyung; Cho, Nariya; Moon, Woo Kyung; Im, Seock-Ah; Park, In Ae; Noh, Dong-Young Annals of Surgery, Vol.257 No.1, pp.133-137	DOI
2013-03	Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II-III invasive breast cancer: the OOTR-N001 study Chow, Louis W. C.; Tung, Stewart Y.; Ng, Ting-Ying; Im, Seock-Ah; Lee, Min-Hyuk; Yip, Adrian Y. S.; Toi, Masakazu; Glueck, Stefan Expert Opinion on Investigational Drugs, Vol.22 No.3, pp.299-307	DOI
2013-12	Establishment and characterization of seven human breast cancer cell lines including two triple-negative cell lines Ku, Ja-Lok; Park, Sung-Chan; Kim, Kyung-Hee; Jeon, You-Kyung; Kim, Sung-Hee; Shin, Young-Kyoung; Noh, Dong-Young; Im, Seock-Ah; Bang, Yung-Jue; Han, Wonshik; Kim, Woo Ho; Park, Jae-Gahb International Journal of Oncology, Vol.43 No.6, pp.2073-2081	DOI
2014-02	Potential Prognostic Value of Histone Deacetylase 6 (HDAC6) Combined with Heat Shock Protein 90 (HSP90) in Breast Cancer 박영희	view file
2014-02	The Comparison of HER2 Targetability between Affibody and Antibody in Nude Mice Bearing Human Breast Cancer Xenograft 임일한	view file
2014-03	Mammographic density and risk of breast cancer in Korean women. [Epub ahead of print] Kim, Bo-Kyoung; Choi, Yoon-Ho; Nguyen, Tuong L.; Nam, Seok Jin; Lee, Jeong Eon; Hopper, John L.; Sung, Joohon; Song, Yun-Mi European Journal of Cancer Prevention, Vol.3, pp. 1-8	DOI
2014-05	Daily Collection of Self-Reporting Sleep Disturbance Data via a Smartphone App in Breast Cancer Patients Receiving Chemotherapy: A Feasibility Study Min, Yul Ha; Lee, Jong Won; Shin, Yong-Wook; Jo, Min-Woo; Sohn, Guiyun; Lee, Jae-Ho; Lee, Guna; Jung, Kyung Hae; Sung, Joohon; Ko, Beom Seok; Yu, Jong-Han; Kim, Hee Jeong; Son, Byung Ho; Ahn, Sei Hyun JOURNAL OF MEDICAL INTERNET RESEARCH, Vol.16 No.5, pp.87-100	DOI
2015-01	ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy Kim, Hee-Jun; Im, Seock-Ah; Keam, Bhumsuk; Ham, Hye Seon; Lee, Kyung Hun; Kim, Tae Yong; Kim, Yu Jung; Oh, Do-Youn; Kim, Jee Hyun; Han, Wonshik; Jang, In-Jin; Kim, Tae-You; Park, In Ae; Noh, Dong Young Cancer Science, Vol.106 No.1, pp.86-93	DOI
2015-02	Exome sequencing 과 gene expression profiling을 이용한 유방암 발생과 관련한 기능성 변이 발굴 정소연	view file
2015-04	Heme oxygenase-1 determines the differential response of breast cancer and normal cells to piperlongumine Lee, Ha-Na; Jin, Hyeon-Ok; Park, Jin-Ah; Kim, Jin-Hee; Kim, Ji-Young; Kim, BoRa; Kim, Wonki; Hong, Sung-Eun; Lee, Yun-Han; Chang, Yoon Hwan; Hong, Seok-Il; Hong, Young Jun; Park, In-Chul; Surh, Young-Joon; Lee, Jin Kyung Molecules and Cells, Vol.38 No.4, pp.327-335	DOI
2016-02	Discovery of novel amplified genes in primary breast cancer with copy number and gene expression analysis of whole exome and transcriptome sequencing data 임우성	view file
2016-05	Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer Seo, An Na; Lee, Hee Jin; Kim, Eun Joo; Jang, Min Hye; Kim, Yu Jung; Kim, Jee Hyun; Kim, Sung-Won; Ryu, Han Suk; Park, In Ae; Im, Seock-Ah; Gong, Gyungyub; Jung, Kyung Hae; Kim, Hee Jeong; Park, So Yeon British Journal of Cancer, Vol.114 No.10, pp.1109-1116	DOI
2016-08	Concurrent inhibition of GLI and SMO is a novel therapeutic strategy to control Breast Cancer Stem Cells 강희정	view file
2016-10	Longitudinal Association of Poor Sleep Quality With Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer Jung, Dooyoung; Lee, Kwang-Min; Kim, Won-Hyoung; Lee, Joo-Young; Kim, Tae-Yong; Im, Seock-Ah; Lee, Kyung-Hun; Spiegel, David; Hahm, Bong-Jin Psychosomatic Medicine, Vol.78 No.8, pp.959-965	DOI
2017-01	Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells Kim, Hee-Jun; Min, Ahrum; Im, Seock-Ah; Jang, Hyemin; Lee, Kyung Hun; Lau, Alan; Lee, Miso; Kim, Seongyeong; Yang, Yaewon; Kim, Jungeun; Kim, Tae Yong; Oh, Do-Youn; Brown, Jeffrey; O'Connor, Mark J.; Bang, Yung-Jue International Journal of Cancer, Vol.140 No.1, pp.109-119	DOI
2017-01	4-Hydroxyestradiol induces mammary epithelial cell transformation through Nrf2-mediated heme oxygenase-1 overexpression Park, Sin-Aye; Lee, Mee-Hyun; Na, Hye-Kyung; Surh, Young-Joon Oncotarget, Vol.8 No.1, pp.164-178	DOI
2017-04	First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors Bang, Y. J.; Giaccone, G.; Im, S. A.; Oh, D. Y.; Bauer, T. M.; Nordstrom, J. L.; Li, H.; Chichili, G. R.; Moore, P. A.; Hong, S.; Stewart, S. J.; Baughman, J. E.; Lechleider, R. J.; Burris, H. A. Annals of Oncology, Vol.28 No.4, pp.855-861	DOI
2017-12	Quality of life on TSU-68: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline Sohn, Byeong Seok; Kim, Sung-Bae; Ahn, Jin-Hee; Jung, Kyung Hae; Kim, Jeongeun; Lee, Keun Seok; Ro, Jungsil; Im, Seock Ah; Im, Young-Hyuck; Song, Hong Suk; Park, Hee Sook; Chung, Hyun-Cheol Asia-Pacific Journal of Clinical Oncology, Vol.13 No.6, pp.365-371	DOI
2018-02	PPM1H Regulates the Response to Paclitaxel in Triple Negative Breast Cancer. 허샘	view file
2018-12	A phase II trial of the pan-HER inhibitor poziotinib, in patients with HER2-positive metastatic breast cancer who had received at least two prior HER2-directed regimens: results of the NOV120101-203 trial Park, Yeon Hee; Lee, Kyung-Hun; Sohn, Joo Hyuk; Lee, Keun Seok; Jung, Kyung Hae; Kim, Jee-Hyun; Lee, Ki Hyeong; Ahn, Jin Seok; Kim, Tae-Yong; Kim, Gun Min; Park, In Hae; Kim, Sung-Bae; Kim, Se Hyun; Han, Hye Sook; Im, Young-Hyuck; Ahn, Jin-Hee; Kim, Jung-Yong; Kang, Jahoon; Im, Seock-Ah International Journal of Cancer, Vol.143 No.12, pp.3240-3247	DOI
2019-03	15-Deoxy-Δ 12,14 -prostaglandin J 2 up-regulates the expression of 15-hydroxyprostaglandin dehydrogenase through DNA methyltransferase 1 inactivation Jang, Hye-Ok; Lee, Ha-Na; Woo, Jeong-Hwa; Lee, Ja-Young; Kim, Areumnuri; Lee, Jin Kyung; Kim, Do-Hee; Surh, Young-Joon; Na, Hye-Kyung Free Radical Research, Vol.53 No.3, pp.335-347	DOI
2019-04	OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer Robson, M. E.; Tung, N.; Conte, P.; Im, S. -A.; Senkus, E.; Xu, B.; Masuda, N.; Delaloge, S.; Li, W.; Armstrong, A.; Wu, W.; Goessl, C.; Runswick, S.; Domchek, S. M. Annals of Oncology, Vol.30 No.4, pp.558-566	DOI
2019-08	A seed coat extract of Yak-Kong as a potential alternative to selective aromatase modulator 박수민	view file link

1 2 3